![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2022
zu Natrup, Christian Meyer; Tscherne, Alina; Dahlke, Christine; Ciurkiewicz, Malgorzata; Shin, Dai-Lun; Fathi, Anahita; Rohde, Cornelius; Kalodimou, Georgia; Halwe, Sandro; Limpinsel, Leonard; Schwarz, Jan H.; Klug, Martha; Esen, Meral; Schneiderhan-Marra, Nicole; Dulovic, Alex; Kupke, Alexandra; Brosinski, Katrin; Clever, Sabrina; Schuenemann, Lisa-Marie; Beythien, Georg; Armando, Federico; Mayer, Leonie; Weskamm, Marie L.; Jany, Sylvia; Freudenstein, Astrid; Tuchel, Tamara; Baumgaertner, Wolfgang; Kremsner, Peter; Fendel, Rolf; Addo, Marylyn M.; Becker, Stephan; Sutter, Gerd und Volz, Asisa
(2022):
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity.
In: Journal of Clinical Investigation, Bd. 132, Nr. 24, e159895
Kupke, Alexandra; Volz, Asisa; Dietzel, Erik; Freudenstein, Astrid; Schmidt, Jörg; Shams-Eldin, Hosam; Jany, Sylvia; Sauerhering, Lucie; Krähling, Verena; Serra, Michelle Gellhorn; Herden, Christiane; Eickmann, Markus; Becker, Stephan und Sutter, Gerd
(2022):
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein.
In: Vaccines, Bd. 10, Nr. 4, 533
2020
Kalodimou, Georgia; Veit, Svenja; Jany, Sylvia; Kalinke, Ulrich; Broder, Christopher C.; Sutter, Gerd 
ORCID: https://orcid.org/0000-0001-6143-082X und Volz, Asisa
(2020):
A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice.
In: Viruses, Bd. 12, Nr. 1, 26
[PDF, 2MB]
ORCID: https://orcid.org/0000-0001-6143-082X und Volz, Asisa
(2020):
A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice.
In: Viruses, Bd. 12, Nr. 1, 26
[PDF, 2MB]
2018
Veit, Svenja; Jany, Sylvia; Fux, Robert; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X und Volz, Asisa
(2018):
CD8+T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
In: Viruses, Bd. 10, Nr. 12, 718
[PDF, 2MB]
ORCID: https://orcid.org/0000-0001-6143-082X und Volz, Asisa
(2018):
CD8+T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
In: Viruses, Bd. 10, Nr. 12, 718
[PDF, 2MB]
Volz, Asisa; Jany, Sylvia; Freudenstein, Astrid; Lantermann, Markus; Ludwig, Holger und Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X
(2018):
E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
In: Viruses, Bd. 10, Nr. 1, 21
[PDF, 1MB]
ORCID: https://orcid.org/0000-0001-6143-082X
(2018):
E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
In: Viruses, Bd. 10, Nr. 1, 21
[PDF, 1MB]
2016
Volz, Asisa; Lim, Stephanie; Kaserer, Martina; Lülf, Anna; Marr, Lisa; Jany, Sylvia; Deeg, Cornelia A.; Pijlman, Gorben P.; Koraka, Penelope; Osterhaus, Albert D. M. E.; Martina, Byron E. und Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X
(2016):
Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
In: Vaccine, Bd. 34, Nr. 16: S. 1915-1926
ORCID: https://orcid.org/0000-0001-6143-082X
(2016):
Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
In: Vaccine, Bd. 34, Nr. 16: S. 1915-1926